Recently published studies have found an impaired immune response after SARS‐CoV‐2
vaccination in solid organ recipients. However, most of these studies have not assessed …

Solid organ transplant recipients are at high risk of severe disease from COVID-19. We
assessed the immunogenicity of mRNA-1273 vaccine using a combination of antibody …

According to preliminary data, seroconversion after mRNA SARS‐CoV‐2 vaccination might
be unsatisfactory in Kidney Transplant Recipients (KTRs). However, it is unknown if …

Background. Severe acute respiratory syndrome coronavirus 2–specific cell-mediated
immunity (SARS-CoV-2-CMI) elicited by mRNA-based vaccines in solid organ transplant …

Limited data are available on risks and benefits of anti‐SARS‐CoV2 vaccination in solid
organ transplant recipients, and weaker responses have been described. At the Italian …

Background. A weak immunogenicity has been reported in solid organ transplant (SOT)
recipients after 2 doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Prior studies have demonstrated a decreased humoral response in solid organ transplant
recipients (SOTRs) to severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) …

Vaccination against SARS-CoV-2 infection is currently approved and shows favorable
outcomes, but little known about antibody responses in solid organ transplant recipients …

A Third Vaccine Dose in Organ-Transplant Recipients It is known that people receiving
immune suppressive therapy, such as recipients of solid-organ transplants, have a …

Background & Aims Liver transplant recipients (LTRs) show a decreased immune response
after 2 severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) vaccinations …